The intracellular pathway for the presentation of Vitamin B-related antigens by the antigen-presenting molecule MR1

Nature Immunology

Volumn 17, Issue 5, 2016, Pages 531-537

  McWilliam, Hamish E G ^a,b   Eckle, Sidonia B G ^a   Theodossis, Alex ^b   Liu, Ligong ^c   Chen, Zhenjun ^a   Wubben, Jacinta M ^b   Fairlie, David P ^c   Strugnell, Richard A ^a   Mintern, Justine D ^d   McCluskey, James ^a   Rossjohn, Jamie ^b,e   Villadangos, Jose A ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 OXOPROPYLIDENEAMINO) 6 DEXTRO RIBITYLAMINOURACIL; ACETY O FORMYLPTERIN; LIGAND; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METHYLGLYOXAL; MR1 ANTIGEN; PTERIN DERIVATIVE; SCHIFF BASE; UNCLASSIFIED DRUG; URACIL DERIVATIVE; VITAMIN B RELATED ANTIGEN; ANTIGEN; HLA ANTIGEN CLASS 1; MR1 PROTEIN, HUMAN; PROTEIN BINDING; VITAMIN B COMPLEX;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOME; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LYMPHOCYTE MIGRATION; MUCOSAL ASSOCIATED INVARIANT T CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; STEADY STATE; CELL CULTURE; CELL LINE; CONFOCAL MICROSCOPY; GENETICS; HELA CELL LINE; IMMUNOBLOTTING; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANTIGEN PRESENTATION; ANTIGENS; CELL LINE; CELL MEMBRANE; CELLS, CULTURED; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOMES; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SPACE; MICROSCOPY, CONFOCAL; PROTEIN BINDING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; VITAMIN B COMPLEX;

EID: 84962106819     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3416     Document Type: Article

References (35)

1. Rossjohn, J. et al. T cell antigen receptor recognition of antigen-presenting molecules. Annu. Rev. Immunol. 33, 169-200 (2015).
2. Pamer, E., Cresswell, P. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16, 323-358 (1998).
3. Heemels, M.T., Ploegh, H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64, 463-491 (1995).
4. Villadangos, J.A. Presentation of antigens by MHC class II molecules: getting the most out of them. Mol. Immunol. 38, 329-346 (2001).
5. Barral, D.C., Brenner, M.B. CD1 antigen presentation: how it works. Nat. Rev. Immunol. 7, 929-941 (2007).
6. Corbett, A.J. et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509, 361-365 (2014).
7. Kjer-Nielsen, L. et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491, 717-723 (2012).
8. McWilliam, H.E., Birkinshaw, R.W., Villadangos, J.A., McCluskey, J., Rossjohn, J. MR1 presentation of vitamin B-based metabolite ligands. Curr. Opin. Immunol. 34, 28-34 (2015).
9. Eckle, S.B. et al. Recognition of vitamin B precursors and byproducts by mucosal associated invariant T cells. J. Biol. Chem. 290, 30204-30211 (2015).
10. Eckle, S.B. et al. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J. Exp. Med. 211, 1585-1600 (2014).
11. Reantragoon, R. et al. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J. Exp. Med. 209, 761-774 (2012).
12. Patel, O. et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat. Commun. 4, 2142 (2013).
13. Gapin, L. Check MAIT. J. Immunol. 192, 4475-4480 (2014).
14. Gold, M.C., Lewinsohn, D.M. Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat. Rev. Microbiol. 11, 14-19 (2013).
15. Sakala, I.G. et al. Functional heterogeneity and antimycobacterial effects of mouse mucosal-associated invariant T cells specific for riboflavin metabolites. J. Immunol. 195, 587-601 (2015).
16. Soudais, C. et al. In vitro and in vivo analysis of the Gram-negative bacteria-derived riboflavin precursor derivatives activating mouse MAIT cells. J. Immunol. 194, 4641-4649 (2015).
17. Gold, M.C. et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 8, e1000407 (2010).
18. Le Bourhis, L. et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat. Immunol. 11, 701-708 (2010).
19. Huang, S. et al. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J. Exp. Med. 205, 1201-1211 (2008).
20. Ahner, A., Brodsky, J.L. Checkpoints in ER-associated degradation: excuse me, which way to the proteasome Trends Cell Biol. 14, 474-478 (2004).
21. Chua, W.J. et al. Endogenous MHC-related protein 1 is transiently expressed on the plasma membrane in a conformation that activates mucosal-associated invariant T cells. J. Immunol. 186, 4744-4750 (2011).
22. Reantragoon, R. et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J. Exp. Med. 210, 2305-2320 (2013).
23. Morris, A.J., Davenport, R.C., Tolan, D.R. A lysine to arginine substitution at position 146 of rabbit aldolase A changes the rate-determining step to Schiff base formation. Protein Eng. 9, 61-67 (1996).
24. Liu, H., Johnston, A.P.R. A programmable sensor to probe the internalization of proteins and nanoparticles in live cells. Angew. Chem. Int. Ed. 52, 5744-5748 (2013).
25. Reuter, A. et al. Criteria for dendritic cell receptor selection for efficient antibody-targeted vaccination. J. Immunol. 194, 2696-2705 (2015).
26. Neefjes, J., Jongsma, M.L., Paul, P., Bakke, O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11, 823-836 (2011).
27. Godfrey, D.I., Uldrich, A.P., McCluskey, J., Rossjohn, J., Moody, D.B. The burgeoning family of unconventional T cells. Nat. Immunol. 16, 1114-1123 (2015).
28. Van Rhijn, I., Godfrey, D.I., Rossjohn, J., Moody, D.B. Lipid and small-molecule display by CD1 and MR1. Nat. Rev. Immunol. 15, 643-654 (2015).
29. Holst, J. et al. Generation of T-cell receptor retrogenic mice. Nat. Protoc. 1, 406-417 (2006).
30. Huang, S. et al. Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J. Biol. Chem. 280, 21183-21193 (2005).
31. Tilloy, F. et al. An invariant T cell receptor chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted/T cell subpopulation in mammals. J. Exp. Med. 189, 1907-1921 (1999).
32. Hoiseth, S.K., Stocker, B.A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238-239 (1981).
33. Datsenko, K.A., Wanner, B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97, 6640-6645 (2000).
34. Strugnell, R. et al. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect. Immun. 60, 3994-4002 (1992).
35. Reuter, A. et al. Criteria for dendritic cell receptor selection for efficient antibody-targeted vaccination. J. Immunol. 194, 2696-2705 (2015).